SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-072730
Filing Date
2012-10-31
Accepted
2012-10-31 16:33:20
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-18972_110q.htm 10-Q 1122288
2 EX-31.1 a12-18972_1ex31d1.htm EX-31.1 13019
3 EX-31.2 a12-18972_1ex31d2.htm EX-31.2 13761
4 EX-32 a12-18972_1ex32.htm EX-32 11446
  Complete submission text file 0001104659-12-072730.txt   8529184

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thrx-20120930.xml EX-101.INS 1184425
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20120930.xsd EX-101.SCH 76260
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20120930_cal.xml EX-101.CAL 49887
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20120930_lab.xml EX-101.LAB 1264603
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20120930_pre.xml EX-101.PRE 566620
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20120930_def.xml EX-101.DEF 410223
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 121171172
SIC: 2834 Pharmaceutical Preparations